Muscular dystrophy Lamin A/C LMNA gene AAV BiP IPSC Becker muscular dystrophy Titin Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Errance diagnostique POPDC1 Diagnosis Allele-specific silencing therapy Joint laxity Dystrophine Adult SMA Cardiac conduction system Therapy CSF protein Regeneration Myotubes Mutations Acetyltransferase Cancer biomarkers INPP5K Dynamin 2 Heart failure Cardiomyopathy LMNA-related congenital muscular dystrophy Ehlers‐Danlos Syndrome Cardiology Maladies rares Muscle Dystrophie musculaire Clinical trial Laminopathies Actionable gene Myopathies Maladies rares et orphelines Cancer C elegans AAV VECTOR Treatment Allele-specific silencing Lamin A/C nuclei Biomarker Muscle MRI Gene therapy Base de données FAIR RNA interference COVID-19 Duchenne muscular dystrophy LGMD Angiotensin-converting enzyme inhibitors Mouse Congenital muscular dystrophy COL1A1 Myogenesis Dilated cardiomyopathy Lamins Alternative splicing A-type lamin Connective tissue Allele‐specific silencing therapy Biological sciences C2C12 Hypermobile EDS Autophagosome maturation LMNA gene Angiotensin-converting enzyme inhibitor COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders COL6A1 BVES Nuclear envelope CMTX Treatment delay LMNA Emerin Laminopathie Laminopathy GNE Emery-Dreifuss muscular dystrophy Heart Muscle biopsy Centronuclear myopathy Patient registry Calcium handling CRISPR Lamin A/C Myologie Butyrylcholinesterase Rare neuromuscular diseases Neuromuscular diseases Muscular dystrophy MD Rare diseases Myopathy Skeletal muscle Actionability Next generation sequencing A-type lamins Exome